Cole and Jaenisch dig into AI poisoning in pharma manufacturing, how it hides in plain sight, and who should be accountable for catching it.
|Articles|November 2, 2018
- Pharmaceutical Technology-11-02-2018
- Volume 42
- Issue 11
Custom Multi-Shaft Mixer
Ross, Charles & Son added a custom 150-gallon Triple Shaft Mixer, the Ross VersaMix Model VMC-150, with elaborate automation and safety functions.
Advertisement
Charles Ross & Son Company has customized 150-gallon Triple Shaft Mixer, the Ross VersaMix Model VMC-150, with elaborate automation and safety functions.
Features include six pneumatic clamps rated for 4000 lbs each for remote locking of the mix vessel cover, which is designed for 29.5-in. Hg vacuum and 5-psi internal pressure.
The mixer also includes automated valves for powder feed and clean-in-place liquids, a resistance-temperature detecting multi-point temperature sensor, built-in vacuum pump assembly, load cell system, and a centralized human machine interface. The VMC-150 features a helical auger screw for submerging floating agglomerates. When reversed, the auger screw surfaces air pockets resulting in decreased batch cycle time.
Articles in this issue
almost 8 years ago
Guidelines on Integral Drug-Device Combinationsalmost 8 years ago
Detachable AODD Pumpalmost 8 years ago
Advanced Paddle Blender for Labsalmost 8 years ago
Bioimaging Molecular Probesalmost 8 years ago
User Requirements Specifications–How Difficult Can It Be?almost 8 years ago
Single-Use Bioprocessing Equipment Trends and Adoption by CMOsalmost 8 years ago
Innovations in Prefilled Syringes for Biologic Drugsalmost 8 years ago
Media Requirements for Different Cell SourcesAdvertisement
Related to this article
Mahmood Majeed, ZS, explains why measurable AI outcomes in pharma supply chain and manufacturing jumped from 29% to 53%, and how GMP limits and GxP validation shape adoption.
BMS-Tempus, Roche-Zymeworks, and LGM-Sannova deals show what AI data, trispecifics, and nitrosamine testing mean for CMC, QA, and development teams.
Univar Solutions scientists developed a lidocaine cream built on starch, sorbitol, coconut oil, and beeswax that matched a commercial benchmark on viscosity, assay, and hydration.
Nate Edwards of Arya Consulting moderates a discussion with Elisabeth Gardiner of Tevard Biosciences and Donny Xu of the RTW Institute about the regulatory and manufacturing hurdles facing rare disease drug developers.
FDA grants ravulizumab accelerated approval in IgA nephropathy after a 43.4% proteinuria cut, signaling new IV biologic demand for drug manufacturers.
Jane Zhang of ETCH Sourcing explains why geopolitics, transparency, and partnership now weigh as heavily as cost and quality when companies choose suppliers, in this episode of Ask the Expert, moderated by Susan J. Schniepp of Nelson Labs.
FDA approves GSK's bepirovirsen for chronic hepatitis B after a 19% functional cure rate, raising oligonucleotide scale-up stakes for manufacturers.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Nitrosamine Problems and Industry Solutions: PharmTech Explained
2
Formulation and Evaluation of a Sustainable Analgesic Cream Utilizing Renewable Bio-Based Ingredients and Green Chemistry Design Principles
3
OpenAI Bets on Accelerating Drug Development Timelines With Orchestra Bio
4
Why BMS, Roche, and LGM Pharma Outsourced Key Capabilities
5